| 212 Psychotherapy Llc | |
|
7109 Brindley Cir Madison WI 53719-2128 | |
| (608) 205-8650 | |
| Not Available |
| Full Name | 212 Psychotherapy Llc |
|---|---|
| Speciality | Counselor |
| Location | 7109 Brindley Cir, Madison, Wisconsin |
| Authorized Official Name and Position | Tanya Kc Hiser (OWNER) |
| Authorized Official Contact | 6085164347 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| 212 Psychotherapy Llc 7109 Brindley Cir Madison WI 53719-2128 Ph: (608) 516-4347 | 212 Psychotherapy Llc 7109 Brindley Cir Madison WI 53719-2128 Ph: (608) 205-8650 |
| NPI Number | 1053941666 |
|---|---|
| Provider Enumeration Date | 01/22/2020 |
| Last Update Date | 05/09/2024 |
| Certification Date | 05/09/2024 |
| Medicare PECOS PAC ID | 9234547829 |
|---|---|
| Medicare Enrollment ID | O20210420002439 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053941666 | NPI | - | NPPES |
| 43741200 | Medicaid | WI | |
| 100098189 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Provider Name | Faith J Lerner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1891756771 PECOS PAC ID: 6800952821 Enrollment ID: I20090226000656 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Sarah L Splinter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770729592 PECOS PAC ID: 3072786490 Enrollment ID: I20111101000119 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Sara Kelly |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922318377 PECOS PAC ID: 9032455381 Enrollment ID: I20190108002595 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Nichole Ashley Sloniker |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1982349106 PECOS PAC ID: 9739566340 Enrollment ID: I20220520001800 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Amysue Sue Hartman |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1568747475 PECOS PAC ID: 0648614651 Enrollment ID: I20240219000421 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Heather J Liebe |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1821518259 PECOS PAC ID: 9739523762 Enrollment ID: I20240219001158 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
| Provider Name | Carmen D Sperle |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1487311452 PECOS PAC ID: 3971948928 Enrollment ID: I20240229000640 |
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
News Archive
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.
Royal Philips, a global leader in health technology, today announced the launch of its Xplore web-based informatics platform for drug research and biomarker discovery.
› Verified 9 days ago
Nrrc, Sc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 702 N Blackhawk Ave, Suite 100, Madison, WI 53705 Phone: 608-441-6159 Fax: 608-663-5928 | |
Creating Space, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1915 Winnebago St Ste 101, Madison, WI 53704 Phone: 608-205-8205 Fax: 608-999-7313 | |
Think & Grow Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2921 Landmark Pl Ste 215, Madison, WI 53713 Phone: 608-957-7277 Fax: 608-252-1333 | |
Adhd Solutions, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 437 S Yellowstone Dr Ste 217b, Madison, WI 53719 Phone: 608-467-2332 | |
Golden Mend Wellness And Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 E Olin Ave Ste 220, Madison, WI 53713 Phone: 608-729-8696 | |
The Family Resource Group Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 313 Price Pl Ste 11, Madison, WI 53705 Phone: 608-575-7518 | |
Wisconsin Young Autism Project Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6402 Odana Rd, Madison, WI 53719 Phone: 608-288-9040 Fax: 608-288-9042 |